Cargando…

Prevalence of Epithelial Ovarian Cancer Stem Cells Correlates with Recurrence in Early-Stage Ovarian Cancer

Epithelial ovarian cancer stem cells (EOC stem cells) have been associated with recurrence and chemoresistance. CD44 and CK18 are highly expressed in cancer stem cells and function as tools for their identification and characterization. We investigated the association between the number of CD44+ EOC...

Descripción completa

Detalles Bibliográficos
Autores principales:	Steffensen, Karina Dahl, Alvero, Ayesha B., Yang, Yang, Waldstrøm, Marianne, Hui, Pei, Holmberg, Jennie C., Silasi, Dan-Arin, Jakobsen, Anders, Rutherford, Thomas, Mor, Gil
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2011
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3166719/ https://www.ncbi.nlm.nih.gov/pubmed/21904548 http://dx.doi.org/10.1155/2011/620523

Ejemplares similares

MyD88 predicts chemoresistance to paclitaxel in epithelial ovarian cancer
por: Silasi, Dan-Arin, et al.
Publicado: (2007)

Constitutive Proteasomal Degradation of TWIST-1 in Epithelial Ovarian Cancer Stem Cells Impacts Differentiation and Metastatic Potential
por: Yin, Gang, et al.
Publicado: (2012)

Phenotypic modifications in ovarian cancer stem cells following Paclitaxel treatment
por: Craveiro, Vinicius, et al.
Publicado: (2013)

Phenotypic modifications in ovarian cancer stem cells following Paclitaxel treatment
por: Craveiro, Vinicius, et al.
Publicado: (2013)

Automated Assay of a Four-Protein Biomarker Panel for Improved Detection of Ovarian Cancer
por: Walker, Christopher, et al.
Publicado: (2021)

Immunohistochemical Expression of Platelet-Derived Growth Factor Receptors in Ovarian Cancer Patients with Long-Term Follow-Up
por: Madsen, Christine Vestergaard, et al.
Publicado: (2012)

Lack of relationship between TIMP-1 tumour cell immunoreactivity, treatment efficacy and prognosis in patients with advanced epithelial ovarian cancer
por: Steffensen, Karina Dahl, et al.
Publicado: (2010)

TWISTing Stemness, Inflammation, and Proliferation of Epithelial Ovarian Cancer Cells through MIR199A2/214
por: Yin, Gang, et al.
Publicado: (2010)

Ovulation and extra-ovarian origin of ovarian cancer
por: Yang-Hartwich, Yang, et al.
Publicado: (2014)

Comment on “Osteopontin, Macrophage Migration Inhibitory Factor and Anti-Interleukin-8 Autoantibodies Complement CA125 for Detection of Early Stage Ovarian Cancer” Cancers 2019, 11, 596: Markers for Early Detection of Ovarian Cancer
por: Mor, Gil, et al.
Publicado: (2019)

Prognostic significance of baseline T cells, B cells and neutrophil-lymphocyte ratio (NLR) in recurrent ovarian cancer treated with chemotherapy
por: Henriksen, Jon Røikjær, et al.
Publicado: (2020)

The Duplicitous Origin of Ovarian Cancer
por: Mor, Gil, et al.
Publicado: (2013)

Prognostic Impact of Circulating Methylated Homeobox A9 DNA in Patients Undergoing Treatment for Recurrent Ovarian Cancer
por: Faaborg, Louise, et al.
Publicado: (2022)

Identification of high-risk patients by human epididymis protein 4 levels during follow-up of ovarian cancer
por: STEFFENSEN, KARINA DAHL, et al.
Publicado: (2016)

Novel approach for the detection of intraperitoneal micrometastasis using an ovarian cancer mouse model
por: Alvero, Ayesha B., et al.
Publicado: (2017)

Serial measurements of serum PDGF-AA, PDGF-BB, FGF2, and VEGF in multiresistant ovarian cancer patients treated with bevacizumab
por: Madsen, Christine Vestergaard, et al.
Publicado: (2012)

Murine Model for Non-invasive Imaging to Detect and Monitor Ovarian Cancer Recurrence
por: Sumi, Natalia J., et al.
Publicado: (2014)

Clostridium perfringens enterotoxin carboxy-terminal fragment is a novel tumor-homing peptide for human ovarian cancer
por: Cocco, Emiliano, et al.
Publicado: (2010)

Regulatory Role of the Adipose Microenvironment on Ovarian Cancer Progression
por: Chehade, Hussein, et al.
Publicado: (2022)

The Long Non-Coding RNA SNHG12 as a Mediator of Carboplatin Resistance in Ovarian Cancer via Epigenetic Mechanisms
por: Abildgaard, Cecilie, et al.
Publicado: (2022)

Immunological modifications following chemotherapy are associated with delayed recurrence of ovarian cancer
por: Adzibolosu, Nicholas, et al.
Publicado: (2023)

KSP inhibitor ARRY-520 as a substitute for Paclitaxel in Type I ovarian cancer cells
por: Kim, Ki Hyung, et al.
Publicado: (2009)

Single-cell and bulk RNA sequencing reveal ligands and receptors associated with worse overall survival in serous ovarian cancer
por: Carvalho, Robson Francisco, et al.
Publicado: (2022)

MNRR1 is a driver of ovarian cancer progression
por: Chehade, Hussein, et al.
Publicado: (2023)

Multiple blocks in the engagement of oxidative phosphorylation in putative ovarian cancer stem cells: implication for maintenance therapy with glycolysis inhibitors
por: Alvero, Ayesha B., et al.
Publicado: (2014)

TWIST1 induces proteasomal degradation of β-catenin during the differentiation of ovarian cancer stem-like cells
por: Liu, Jiaqi, et al.
Publicado: (2022)

Transimmunization restores immune surveillance and prevents recurrence in a syngeneic mouse model of ovarian cancer
por: Alvero, Ayesha B., et al.
Publicado: (2020)

Adipose-derived exosomal miR-421 targets CBX7 and promotes metastatic potential in ovarian cancer cells
por: Zhang, Yi, et al.
Publicado: (2023)

Adipose-derived exosomal miR-421 targets CBX7 and promotes metastatic potential in ovarian cancer cells
por: Zhang, Yi, et al.
Publicado: (2023)

Recent insights into the role of NF-kappaB in ovarian carcinogenesis
por: Alvero, Ayesha B
Publicado: (2010)

Proactive use of PROMs in ovarian cancer survivors: a systematic review
por: Kargo, Anette Stolberg, et al.
Publicado: (2019)

Post-mortem testing; germline BRCA1/2 variant detection using archival FFPE non-tumor tissue. A new paradigm in genetic counseling
por: Petersen, Annabeth Høgh, et al.
Publicado: (2016)

MicroRNA-222-3p/GNAI2/AKT axis inhibits epithelial ovarian cancer cell growth and associates with good overall survival
por: Fu, Xiaodan, et al.
Publicado: (2016)

Ovarian seromucinous carcinoma: an independent epithelial ovarian cancer?
por: Hu, Yi, et al.
Publicado: (2023)

Shared decision making in recurrent ovarian cancer: Implementation of patient decision aids across three departments of oncology in Denmark
por: Wulff, Christian Nielsen, et al.
Publicado: (2022)

Treatment of recurrent epithelial ovarian cancer
por: Pisano, Carmela, et al.
Publicado: (2009)

Treatment of Recurrent Epithelial Ovarian Cancer
por: Claussen, Carlota, et al.
Publicado: (2020)

Generation of Stable Epithelial–Mesenchymal Hybrid Cancer Cells with Tumorigenic Potential
por: Tedja, Roslyn, et al.
Publicado: (2023)

Development, implementation and evaluation of patient decision aids supporting shared decision making in women with recurrent ovarian cancer
por: Hæe, Mette, et al.
Publicado: (2022)

Hyperthermic intraperitoneal chemotherapy for recurrent epithelial ovarian cancer
por: Chen, Wei-Chun, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_20fcfrpu1sg60b4ci2qu828388